IDS Member

Professor Benjamin Becker’s MIND & AI Lab drives innovation at the intersection of neuropsychology and artificial intelligence to advance mental health and social-cognitive affective sciences. Leveraging recent technological and computational advances, the lab investigates the neural underpinnings of social-cognitive and affective processes in humans, focusing on how these processes:

1. shape and are shaped by interactions with emerging technologies and new forms of intelligence (such as social media and AI),
2. become dysregulated in mental disorders (including anxiety, depression, and addiction), and
3. can be modulated by neuropeptides (e.g., oxytocin, renin-angiotensin system) or brain-inspired technologies (e.g., non-invasive brain stimulation, real-time neurofeedback).

Professor Becker’s international team employs a comprehensive array of methodologies—from neuropsychology and cognitive neuroscience to experimental psychology, advanced neuroimaging, AI, machine learning-based neural decoding, computational modeling, and both pharmacological and real-time fMRI-guided neuromodulation—in healthy and clinical populations. The team’s findings, published in over 300 articles in leading scientific journals, have been successfully translated into randomized clinical trials, paving the way for innovative mental health interventions and policy development.

Currently, Professor Becker serves as Principal Editor of Psychopharmacology, Executive Board Member of Advanced Science, and Editor of Psychotherapy and Psychosomatics. He also co-directs the CIBD Task Force of the Global Brain Consortium (GBC) and has been recognized among the World’s Top 1% (Clarivate) or Top 2% (Stanford) scientists.